Report Detail

Other Global Influenza Vaccine Market Professional Survey Report 2018

  • RnM1774065
  • |
  • 17 July, 2018
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Other

This report studies the global Influenza Vaccine market status and forecast, categorizes the global Influenza Vaccine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes.
The global Influenza Vaccine market is valued at 3090 million US$ in 2017 and will reach 5270 million US$ by the end of 2025, growing at a CAGR of 6.9% during 2018-2025.

The major manufacturers covered in this report
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Trivalent
Quadrivalent

By Application, the market can be split into
Adults
Pediatrics

The study objectives of this report are:
To analyze and study the global Influenza Vaccine capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Influenza Vaccine manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Influenza Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Influenza Vaccine Manufacturers
Influenza Vaccine Distributors/Traders/Wholesalers
Influenza Vaccine Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Influenza Vaccine market, by end-use.
Detailed analysis and profiles of additional market players.


Table of Contents

    Global Influenza Vaccine Market Professional Survey Report 2018

      1 Industry Overview of Influenza Vaccine

      • 1.1 Definition and Specifications of Influenza Vaccine
        • 1.1.1 Definition of Influenza Vaccine
        • 1.1.2 Specifications of Influenza Vaccine
      • 1.2 Classification of Influenza Vaccine
        • 1.2.1 Trivalent
        • 1.2.2 Quadrivalent
      • 1.3 Applications of Influenza Vaccine
        • 1.3.1 Adults
        • 1.3.2 Pediatrics
      • 1.4 Market Segment by Regions
        • 1.4.1 North America
        • 1.4.2 Europe
        • 1.4.3 China
        • 1.4.4 Japan
        • 1.4.5 Southeast Asia
        • 1.4.6 India

      2 Manufacturing Cost Structure Analysis of Influenza Vaccine

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Influenza Vaccine
      • 2.3 Manufacturing Process Analysis of Influenza Vaccine
      • 2.4 Industry Chain Structure of Influenza Vaccine

      3 Technical Data and Manufacturing Plants Analysis of Influenza Vaccine

      • 3.1 Capacity and Commercial Production Date of Global Influenza Vaccine Major Manufacturers in 2017
      • 3.2 Manufacturing Plants Distribution of Global Influenza Vaccine Major Manufacturers in 2017
      • 3.3 R&D Status and Technology Source of Global Influenza Vaccine Major Manufacturers in 2017
      • 3.4 Raw Materials Sources Analysis of Global Influenza Vaccine Major Manufacturers in 2017

      4 Global Influenza Vaccine Overall Market Overview

      • 4.1 2013-2018E Overall Market Analysis
      • 4.2 Capacity Analysis
        • 4.2.1 2013-2018E Global Influenza Vaccine Capacity and Growth Rate Analysis
        • 4.2.2 2017 Influenza Vaccine Capacity Analysis (Company Segment)
      • 4.3 Sales Analysis
        • 4.3.1 2013-2018E Global Influenza Vaccine Sales and Growth Rate Analysis
        • 4.3.2 2017 Influenza Vaccine Sales Analysis (Company Segment)
      • 4.4 Sales Price Analysis
        • 4.4.1 2013-2018E Global Influenza Vaccine Sales Price
        • 4.4.2 2017 Influenza Vaccine Sales Price Analysis (Company Segment)

      5 Influenza Vaccine Regional Market Analysis

      • 5.1 North America Influenza Vaccine Market Analysis
        • 5.1.1 North America Influenza Vaccine Market Overview
        • 5.1.2 North America 2013-2018E Influenza Vaccine Local Supply, Import, Export, Local Consumption Analysis
        • 5.1.3 North America 2013-2018E Influenza Vaccine Sales Price Analysis
        • 5.1.4 North America 2017 Influenza Vaccine Market Share Analysis
      • 5.2 Europe Influenza Vaccine Market Analysis
        • 5.2.1 Europe Influenza Vaccine Market Overview
        • 5.2.2 Europe 2013-2018E Influenza Vaccine Local Supply, Import, Export, Local Consumption Analysis
        • 5.2.3 Europe 2013-2018E Influenza Vaccine Sales Price Analysis
        • 5.2.4 Europe 2017 Influenza Vaccine Market Share Analysis
      • 5.3 China Influenza Vaccine Market Analysis
        • 5.3.1 China Influenza Vaccine Market Overview
        • 5.3.2 China 2013-2018E Influenza Vaccine Local Supply, Import, Export, Local Consumption Analysis
        • 5.3.3 China 2013-2018E Influenza Vaccine Sales Price Analysis
        • 5.3.4 China 2017 Influenza Vaccine Market Share Analysis
      • 5.4 Japan Influenza Vaccine Market Analysis
        • 5.4.1 Japan Influenza Vaccine Market Overview
        • 5.4.2 Japan 2013-2018E Influenza Vaccine Local Supply, Import, Export, Local Consumption Analysis
        • 5.4.3 Japan 2013-2018E Influenza Vaccine Sales Price Analysis
        • 5.4.4 Japan 2017 Influenza Vaccine Market Share Analysis
      • 5.5 Southeast Asia Influenza Vaccine Market Analysis
        • 5.5.1 Southeast Asia Influenza Vaccine Market Overview
        • 5.5.2 Southeast Asia 2013-2018E Influenza Vaccine Local Supply, Import, Export, Local Consumption Analysis
        • 5.5.3 Southeast Asia 2013-2018E Influenza Vaccine Sales Price Analysis
        • 5.5.4 Southeast Asia 2017 Influenza Vaccine Market Share Analysis
      • 5.6 India Influenza Vaccine Market Analysis
        • 5.6.1 India Influenza Vaccine Market Overview
        • 5.6.2 India 2013-2018E Influenza Vaccine Local Supply, Import, Export, Local Consumption Analysis
        • 5.6.3 India 2013-2018E Influenza Vaccine Sales Price Analysis
        • 5.6.4 India 2017 Influenza Vaccine Market Share Analysis

      6 Global 2013-2018E Influenza Vaccine Segment Market Analysis (by Type)

      • 6.1 Global 2013-2018E Influenza Vaccine Sales by Type
      • 6.2 Different Types of Influenza Vaccine Product Interview Price Analysis
      • 6.3 Different Types of Influenza Vaccine Product Driving Factors Analysis
        • 6.3.1 Trivalent Growth Driving Factor Analysis
        • 6.3.2 Quadrivalent Growth Driving Factor Analysis

      7 Global 2013-2018E Influenza Vaccine Segment Market Analysis (by Application)

      • 7.1 Global 2013-2018E Influenza Vaccine Consumption by Application
      • 7.2 Different Application of Influenza Vaccine Product Interview Price Analysis
      • 7.3 Different Application of Influenza Vaccine Product Driving Factors Analysis
        • 7.3.1 Adults of Influenza Vaccine Growth Driving Factor Analysis
        • 7.3.2 Pediatrics of Influenza Vaccine Growth Driving Factor Analysis

      8 Major Manufacturers Analysis of Influenza Vaccine

      • 8.1 AstraZeneca
        • 8.1.1 Company Profile
        • 8.1.2 Product Picture and Specifications
          • 8.1.2.1 Product A
          • 8.1.2.2 Product B
        • 8.1.3 AstraZeneca 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.1.4 AstraZeneca 2017 Influenza Vaccine Business Region Distribution Analysis
      • 8.2 CSL
        • 8.2.1 Company Profile
        • 8.2.2 Product Picture and Specifications
          • 8.2.2.1 Product A
          • 8.2.2.2 Product B
        • 8.2.3 CSL 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.2.4 CSL 2017 Influenza Vaccine Business Region Distribution Analysis
      • 8.3 GlaxoSmithKline
        • 8.3.1 Company Profile
        • 8.3.2 Product Picture and Specifications
          • 8.3.2.1 Product A
          • 8.3.2.2 Product B
        • 8.3.3 GlaxoSmithKline 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.3.4 GlaxoSmithKline 2017 Influenza Vaccine Business Region Distribution Analysis
      • 8.4 Sanofi
        • 8.4.1 Company Profile
        • 8.4.2 Product Picture and Specifications
          • 8.4.2.1 Product A
          • 8.4.2.2 Product B
        • 8.4.3 Sanofi 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.4.4 Sanofi 2017 Influenza Vaccine Business Region Distribution Analysis
      • 8.5 Altimmune
        • 8.5.1 Company Profile
        • 8.5.2 Product Picture and Specifications
          • 8.5.2.1 Product A
          • 8.5.2.2 Product B
        • 8.5.3 Altimmune 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.5.4 Altimmune 2017 Influenza Vaccine Business Region Distribution Analysis
      • 8.6 BionVax
        • 8.6.1 Company Profile
        • 8.6.2 Product Picture and Specifications
          • 8.6.2.1 Product A
          • 8.6.2.2 Product B
        • 8.6.3 BionVax 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.6.4 BionVax 2017 Influenza Vaccine Business Region Distribution Analysis
      • 8.7 FluGen
        • 8.7.1 Company Profile
        • 8.7.2 Product Picture and Specifications
          • 8.7.2.1 Product A
          • 8.7.2.2 Product B
        • 8.7.3 FluGen 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.7.4 FluGen 2017 Influenza Vaccine Business Region Distribution Analysis
      • 8.8 FOLIA BIOTECH
        • 8.8.1 Company Profile
        • 8.8.2 Product Picture and Specifications
          • 8.8.2.1 Product A
          • 8.8.2.2 Product B
        • 8.8.3 FOLIA BIOTECH 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.8.4 FOLIA BIOTECH 2017 Influenza Vaccine Business Region Distribution Analysis
      • 8.9 Genentech
        • 8.9.1 Company Profile
        • 8.9.2 Product Picture and Specifications
          • 8.9.2.1 Product A
          • 8.9.2.2 Product B
        • 8.9.3 Genentech 2017 Influenza Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        • 8.9.4 Genentech 2017 Influenza Vaccine Business Region Distribution Analysis

      9 Development Trend of Analysis of Influenza Vaccine Market

      • 9.1 Global Influenza Vaccine Market Trend Analysis
        • 9.1.1 Global 2018-2025 Influenza Vaccine Market Size (Volume and Value) Forecast
        • 9.1.2 Global 2018-2025 Influenza Vaccine Sales Price Forecast
      • 9.2 Influenza Vaccine Regional Market Trend
        • 9.2.1 North America 2018-2025 Influenza Vaccine Consumption Forecast
        • 9.2.2 Europe 2018-2025 Influenza Vaccine Consumption Forecast
        • 9.2.3 China 2018-2025 Influenza Vaccine Consumption Forecast
        • 9.2.4 Japan 2018-2025 Influenza Vaccine Consumption Forecast
        • 9.2.5 Southeast Asia 2018-2025 Influenza Vaccine Consumption Forecast
        • 9.2.6 India 2018-2025 Influenza Vaccine Consumption Forecast
      • 9.3 Influenza Vaccine Market Trend (Product Type)
      • 9.4 Influenza Vaccine Market Trend (Application)

      10 Influenza Vaccine Marketing Type Analysis

      • 10.1 Influenza Vaccine Regional Marketing Type Analysis
      • 10.2 Influenza Vaccine International Trade Type Analysis
      • 10.3 Traders or Distributors with Contact Information of Influenza Vaccine by Region
      • 10.4 Influenza Vaccine Supply Chain Analysis

      11 Consumers Analysis of Influenza Vaccine

      • 11.1 Consumer 1 Analysis
      • 11.2 Consumer 2 Analysis
      • 11.3 Consumer 3 Analysis
      • 11.4 Consumer 4 Analysis

      12 Conclusion of the Global Influenza Vaccine Market Professional Survey Report 2017

        Methodology

          Analyst Introduction

            Data Source


            REPORT YOU MIGHT BE INTERESTED

            Purchase this Report

            $3,500.00
            $7,000.00
            2,768.50
            5,537.00
            3,227.00
            6,454.00
            543,550.00
            1,087,100.00
            292,250.00
            584,500.00
            Credit card Logo

            Related Reports


            Reason to Buy

            Request for Sample of this report